{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:47:10Z","timestamp":1767494830855,"version":"3.48.0"},"reference-count":43,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,10,11]]},"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) affects nearly 9% of global populations and is strongly associated with older age. Neurocognitive disorders (NCDs), which include mild cognitive impairment and dementia, are rising as a result of ageing populations throughout the world. This investigation\u2019s aim is to report the frequency of mild to major NCD in a clinical cohort of adults with mild to moderate CKD and diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Glan Clwyd District general Hospital, North Wales, UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      We enrolled 178 patients with CKD and diabetes, aged 55 years and over with an estimated glomerular filtration rate &lt;60 &gt;15\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      , attending a specialist renal and diabetic outpatient clinic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Frequency of mild and major NCD and the association with the stage of CKD was assessed in all patients attending the specialist clinic. The diagnosis of NCD was based on patient and informant interview, case note review, neuropsychological assessment and application of Diagnostic and Statistical Manual of Mental Disorders version 5.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This investigation found 86\/178 (48%) of the cohort with an NCD ranging from mild (n=49) to major symptoms (n=37). No association was found with NCD and the stage of CKD. Mild and major NCD was associated poorer outcomes in several cognitive domains, including, language, executive, memory, fluency and attention function (p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first UK investigation to report that cognitive changes occur in a significant number of older adults with CKD and diabetes. The unexpected finding was that prior to cognitive assessment, not any of the cohort had a pre-existing diagnosis of cognitive impairment, suggesting that the current prevalence and incidence rates of NCD in the general population are possibly significantly underestimated. Our findings also suggest that the cognitive function of patients with CKD should be screened and monitored routinely as part of their overall care management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-023520","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T05:08:45Z","timestamp":1543986525000},"page":"e023520","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK"],"prefix":"10.1136","volume":"8","author":[{"given":"Peter","family":"Hobson","sequence":"first","affiliation":[{"name":"Academic Unit, Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aled","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Betsi Cadwaladr University Health Board, Rhyl, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Betsi Cadwaladr University Health Board, Rhyl, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Diabetes & Endocrinology, Betsi Cadwaladr University Health Board, Rhyl, Denbighshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mick","family":"Kumwenda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Betsi Cadwaladr University Health Board, Rhyl, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"2025121512580954000_8.12.e023520.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data","volume":"2015","author":"Hedgeman","year":"2015","journal-title":"Int J Nephrol"},{"key":"2025121512580954000_8.12.e023520.2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: systematic review","volume":"8","author":"Zhang","year":"2008","journal-title":"BMC Public Health"},{"key":"2025121512580954000_8.12.e023520.3","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.4.491.61034"},{"key":"2025121512580954000_8.12.e023520.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.095"},{"key":"2025121512580954000_8.12.e023520.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52508.x"},{"key":"2025121512580954000_8.12.e023520.6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000225182.15532.40"},{"key":"2025121512580954000_8.12.e023520.7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101090"},{"key":"2025121512580954000_8.12.e023520.8","doi-asserted-by":"publisher","DOI":"10.1159\/000338135"},{"key":"2025121512580954000_8.12.e023520.9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2016.01.026","article-title":"Cognitive impairment and progression of CKD","volume":"68","author":"Kurella Tamura","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2025121512580954000_8.12.e023520.10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-016-0745-9","article-title":"Cognition in chronic kidney disease: a systematic review and meta-analysis","volume":"14","author":"Berger","year":"2016","journal-title":"BMC Med"},{"key":"2025121512580954000_8.12.e023520.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp230"},{"key":"2025121512580954000_8.12.e023520.12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/j.ajkd.2015.11.008","article-title":"The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function","volume":"67","author":"Murray","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2025121512580954000_8.12.e023520.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.07.003"},{"key":"2025121512580954000_8.12.e023520.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2010.11.002"},{"key":"2025121512580954000_8.12.e023520.15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182553be6"},{"key":"2025121512580954000_8.12.e023520.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61570-6"},{"key":"2025121512580954000_8.12.e023520.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318292a2f9"},{"key":"2025121512580954000_8.12.e023520.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504327"},{"key":"2025121512580954000_8.12.e023520.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70072-2"},{"key":"2025121512580954000_8.12.e023520.20","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4245"},{"key":"2025121512580954000_8.12.e023520.21","unstructured":"Chronic Kidney Disease: Early identification and management of chronic kidney disease in adults in primary and secondary care. NICE Clinical Guideline 2008;73."},{"key":"2025121512580954000_8.12.e023520.22","doi-asserted-by":"publisher","DOI":"10.1159\/000351671"},{"key":"2025121512580954000_8.12.e023520.23","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1765"},{"key":"2025121512580954000_8.12.e023520.24","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edn. Washington DC: American Psychiatric Association, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2025121512580954000_8.12.e023520.25","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.12.1985"},{"key":"2025121512580954000_8.12.e023520.26","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","article-title":"Mild Cognitive Impairment","volume":"364","author":"Petersen","year":"2011","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025121512580954000_8.12.e023520.27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"2025121512580954000_8.12.e023520.28","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025121512580954000_8.12.e023520.29","first-page":"302","article-title":"The prevalence of anaemia in the world","volume":"38","author":"DeMaeyer","year":"1985","journal-title":"World Health Stat Q"},{"key":"2025121512580954000_8.12.e023520.30","unstructured":"IBM CR. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp, 2013."},{"key":"2025121512580954000_8.12.e023520.31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2016.07.055","article-title":"Does mild cognitive impairment always lead to dementia? A review","volume":"369","author":"Pandya","year":"2016","journal-title":"J Neurol Sci"},{"key":"2025121512580954000_8.12.e023520.32","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.531343"},{"key":"2025121512580954000_8.12.e023520.33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/gps.4261","article-title":"Mild cognitive impairment in parkinson\u2019s disease and its progression onto dementia: a 16-year outcome evaluation of the denbighshire cohort","volume":"30","author":"Hobson","year":"2015","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025121512580954000_8.12.e023520.34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829e701d"},{"key":"2025121512580954000_8.12.e023520.35","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02660310"},{"key":"2025121512580954000_8.12.e023520.36","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0226-6"},{"key":"2025121512580954000_8.12.e023520.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00618-8"},{"key":"2025121512580954000_8.12.e023520.38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00125-017-4541-7","article-title":"HbA\n                  1c\n               , diabetes and cognitive decline: the english longitudinal study of ageing","volume":"61","author":"Zheng","year":"2018","journal-title":"Diabetologia"},{"key":"2025121512580954000_8.12.e023520.39","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0737"},{"key":"2025121512580954000_8.12.e023520.40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121512580954000_8.12.e023520.41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-017-0238-x","article-title":"Proportion of dementia in Australia explained by common modifiable risk factors","volume":"9","author":"Ashby-Mitchell","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2025121512580954000_8.12.e023520.42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2040622317712442","article-title":"Strategies for dementia prevention: latest evidence and implications","volume":"8","author":"Rakesh","year":"2017","journal-title":"Ther Adv Chronic Dis"},{"key":"2025121512580954000_8.12.e023520.43","unstructured":"National Clinical Guideline Centre. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care (update): National Institute for Health and Care Excellence, 2014."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-023520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:58:18Z","timestamp":1765832298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-023520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,4]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1136\/bmjopen-2018-023520"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-023520","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}